UW22022
OPEN TO ACCRUAL
Phase II Randomized Trial of Temozolomide and Atezolizumab as Second or ThirdLine Treatment for SCLC
UW23030
OPEN TO ACCRUAL
DARES
UW23047
OPEN TO ACCRUAL
Ph 3 Atezolizumab-Controlled Study of HLX10 + Chemo (Carboplatin-Etoposide) in Patients with ES-SCLC
UW25019
OPEN TO ACCRUAL
HEARTS for Thoracic Cancers Phase II